DISTRIBUTION OF BETA(3)-ADRENOCEPTOR MESSENGER-RNA IN HUMAN TISSUES

被引:154
作者
BERKOWITZ, DE
NARDONE, NA
SMILEY, RM
PRICE, DT
KREUTTER, DK
FREMEAU, RT
SCHWINN, DA
机构
[1] DUKE UNIV,MED CTR,DEPT ANESTHESIOL,DURHAM,NC 27710
[2] PFIZER INC,DIV CENT RES,GROTON,CT 06340
[3] COLUMBIA UNIV,COLL PHYS & SURG,DEPT ANESTHESIOL,NEW YORK,NY 10032
[4] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[5] DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 289卷 / 02期
关键词
BETA(3)-ADRENOCEPTOR; ADIPOSE TISSUE; GALLBLADDER; OBESITY; RNASE PROTECTION; (HUMAN);
D O I
10.1016/0922-4106(95)90098-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The beta(3)-adrenoceptor is a G protein-coupled receptor which mediates metabolic functions of the endogenous catecholamines epinephrine and norepinephrine. Questions exist regarding distribution of the beta(3)-adrenoceptor in human tissue. In order to examine the distribution of beta(3)-adrenoceptor mRNA in human tissues, we used sensitive and specific RNase protection assays without previous PCR amplification in an extensive list of human tissues. We confirm the presence of beta(3)-adrenoceptor mRNA in human white fat from several locations, gall bladder, and small intestine, as well as extend the distribution of beta(3)-adrenoceptor mRNA to previously uncharacterized human tissues such as stomach and prostate. The presence of beta(3)-adrenoceptor mRNA in human white adipose tissue has important implications regarding possible use of beta(3)-adrenoceptor selective agonists as anti-obesity agents, and the demonstration of beta(3)-adrenoceptor mRNA in a number of gastrointestinal tissues and prostate raises the question of the role of the beta(3)-adrenoceptor in motility and secretory processes.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 21 条
  • [1] ATYPICAL BETA-ADRENOCEPTOR ON BROWN ADIPOCYTES AS TARGET FOR ANTI-OBESITY DRUGS
    ARCH, JRS
    AINSWORTH, AT
    CAWTHORNE, MA
    PIERCY, V
    SENNITT, MV
    THODY, VE
    WILSON, C
    WILSON, S
    [J]. NATURE, 1984, 309 (5964) : 163 - 165
  • [2] AGONIST AND ANTAGONIST CHARACTERIZATION OF A PUTATIVE ADRENOCEPTOR WITH DISTINCT PHARMACOLOGICAL PROPERTIES FROM THE ALPHA-SUBTYPES AND BETA-SUBTYPES
    BOND, RA
    CLARKE, DE
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) : 723 - 734
  • [3] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [4] THE HUMAN BETA-3-ADRENOCEPTOR - THE SEARCH FOR A PHYSIOLOGICAL-FUNCTION
    EMORINE, L
    BLIN, N
    STROSBERG, AD
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (01) : 3 - 7
  • [5] MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR
    EMORINE, LJ
    MARULLO, S
    BRIENDSUTREN, MM
    PATEY, G
    TATE, K
    DELAVIERKLUTCHKO, C
    STROSBERG, AD
    [J]. SCIENCE, 1989, 245 (4922) : 1118 - 1121
  • [6] ESBENSHADE TA, 1992, MOL PHARMACOL, V42, P753
  • [7] GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964
  • [8] GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
  • [9] GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264
  • [10] ANTIBODIES FOR THE IMMUNOCHEMISTRY OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR
    GUILLAUME, JL
    PETITJEAN, F
    HAASEMANN, M
    BIANCHI, C
    ESHDAT, Y
    STROSBERG, AD
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 761 - 770